Risk of AIDS-related virus (human immunodeficiency virus) transmission through apheresis procedures
- 1 January 1987
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 3 (3) , 143-146
- https://doi.org/10.1002/jca.2920030302
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Influence of Plasmapheresis on Cellular Immunity*Published by S. Karger AG ,2015
- Inactivation and partition of human T‐cell lymphotrophic virus, type III, during ethanol fractionation of plasmaTransfusion, 1986
- HTLV-III ANTIBODY IN COMMERCIAL IMMUNOGLOBULINThe Lancet, 1986
- The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with aids and aids-related conditionsJournal of Clinical Apheresis, 1986
- Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus III (HTLV-III)New England Journal of Medicine, 1985
- INACTIVATION OF LYMPHADENOPATHY ASSOCIATED VIRUS BY CHEMICAL DISINFECTANTSThe Lancet, 1984
- The Acquired Immunodeficiency Syndrome in Patients with HemophiliaAnnals of Internal Medicine, 1984
- Acquired Immunodeficiency Syndrome (AIDS) Associated with TransfusionsNew England Journal of Medicine, 1984
- The effect of plasmapheresis and drug immunosuppression on T‐cell subsets as defined by monoclonal antibodiesJournal of Clinical Apheresis, 1983
- [29] Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresisPublished by Elsevier ,1983